OncoArendi Therapeutics SA's total assets for Q3 2025 were zł97.15M, a decrease of -5.99% from the previous quarter. PL:MOC total liabilities were zł7.73M for the fiscal quarter, a -10.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.